• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Brachial Plexus Injury Companies

    ID: MRFR/Pharma/2978-HCR
    206 Pages
    Kinjoll Dey
    October 2025

    Brachial plexus injuries involve damage to the network of nerves that control the muscles of the shoulder, arm, and hand. These injuries can occur due to trauma, stretching, or compression of the brachial plexus nerves. Treatment may involve various approaches, including physical therapy, surgical intervention, and supportive care. While there may not be specific companies exclusively focused on brachial plexus injuries, various medical device and healthcare companies provide products and solutions that may be used in the diagnosis and treatment of such injuries.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Brachial Plexus Injury Market Research Report- Forecast till 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Brachial Plexus Injury Market

    Brachial Plexus Injury Key Companies

     

    Latest Brachial Plexus Injury Companies Update


    Integra Life Sciences Launched the SurgiSeal® Nerve Sheath Repair System in May 2023, providing a novel solution for protecting and promoting nerve healing after surgery.


    AxoGen Received FDA approval for their AVANCE® Nerve Graft in September 2023, offering a readily available nerve graft option for BPI repair.


    Synapse Biomedical Partnered with the University of Pittsburgh to develop a biocompatible nerve guide scaffold for BPI treatment using patients' own stem cells.


    Cleveland Clinic Established the Lou Ruvo Center for Brain Health Brain Recovery Program, offering specialized rehabilitation services for BPI patients, including advanced neuromodulation therapies.


    University of California, San Francisco: Researchers developed a microfluidic device that helps predict nerve regeneration potential in BPI patients, potentially aiding in treatment planning.


    List of Brachial Plexus Injury Key Companies in the Market



    • Pfizer (U.S.)

    • Abbvie Inc. (U.S.)

    • Johnson & Johnson (U.S.)

    • GlaxoSmithKline (U.S.)

    • Merck Sharp & Dohme Corp (U.S.)

    • Novartis AG (Germany)

    • Hoffmann-La Roche Ltd (Switzerland)

    • Eli Lily and Company (U.S.)

    • AstraZeneca (U.S.)

    • Amgen (U.S.)